Literature DB >> 12460932

A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells.

John Muschler1, Dinah Levy, Roseanne Boudreau, Michael Henry, Kevin Campbell, Mina J Bissell.   

Abstract

Receptors mediating cell-basement membrane interactions are potent regulators of epithelial architecture and function, and alterations in signals from the basement membrane are implicated in the aberrant behavior of carcinoma cells. In this study, we have investigated the role of the basement membrane receptor dystroglycan (DG) in mammary epithelial cell function, and the significance of loss of DG function in breast tumor cell lines. Nonmalignant mammary epithelial cells express a functional DG. Analysis of multiple breast carcinoma cell lines revealed that DG is expressed in all of the cell lines examined, as evidenced by beta-DG expression, but that alpha-DG is functionally diminished in the majority. High levels of alpha-DG correlated strongly with the ability of cells to polarize in the presence of the basement membrane. Overexpression of the DG cDNA in HMT-3522-T4-2 cells elevated alpha-DG levels and altered responsiveness to the basement membrane; DG overexpression restored the ability of the cells to undergo cytoskeletal changes, to polarize, and to restrict growth in response to basement membrane proteins. Moreover, restoration of DG function to these cells greatly reduced their tumorigenic potential in nude mice. These data point to DG as an important mediator of normal cell responses to the basement membrane, and as a significant variable in carcinoma cells, in which its frequent loss can contribute to aberrant cell behavior.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12460932

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  59 in total

Review 1.  Tissue architecture: the ultimate regulator of breast epithelial function.

Authors:  Mina J Bissell; Aylin Rizki; I Saira Mian
Journal:  Curr Opin Cell Biol       Date:  2003-12       Impact factor: 8.382

Review 2.  Modeling tissue-specific signaling and organ function in three dimensions.

Authors:  Karen L Schmeichel; Mina J Bissell
Journal:  J Cell Sci       Date:  2003-06-15       Impact factor: 5.285

3.  Direct interaction of beta-dystroglycan with F-actin.

Authors:  Yun-Ju Chen; Heather J Spence; Jacqueline M Cameron; Thomas Jess; Jane L Ilsley; Steven J Winder
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

4.  Perlecan and Dystroglycan act at the basal side of the Drosophila follicular epithelium to maintain epithelial organization.

Authors:  Martina Schneider; Ashraf A Khalil; John Poulton; Casimiro Castillejo-Lopez; Diane Egger-Adam; Andreas Wodarz; Wu-Min Deng; Stefan Baumgartner
Journal:  Development       Date:  2006-08-30       Impact factor: 6.868

5.  C. elegans dystroglycan coordinates responsiveness of follower axons to dorsal/ventral and anterior/posterior guidance cues.

Authors:  Robert P Johnson; James M Kramer
Journal:  Dev Neurobiol       Date:  2012-07-27       Impact factor: 3.964

6.  Laminin-6 assembles into multimolecular fibrillar complexes with perlecan and participates in mechanical-signal transduction via a dystroglycan-dependent, integrin-independent mechanism.

Authors:  Jonathan C R Jones; Kimberly Lane; Susan B Hopkinson; Emilia Lecuona; Robert C Geiger; David A Dean; Eduardo Correa-Meyer; Meredith Gonzales; Kevin Campbell; Jacob I Sznajder; Scott Budinger
Journal:  J Cell Sci       Date:  2005-05-31       Impact factor: 5.285

Review 7.  Comparative mechanisms of branching morphogenesis in diverse systems.

Authors:  Pengfei Lu; Mark D Sternlicht; Zena Werb
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-10       Impact factor: 2.673

Review 8.  Unraveling the microenvironmental influences on the normal mammary gland and breast cancer.

Authors:  Britta Weigelt; Mina J Bissell
Journal:  Semin Cancer Biol       Date:  2008-03-26       Impact factor: 15.707

9.  Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts.

Authors:  Karen Fernandez; Yelda Serinagaoglu; Sue Hammond; Laura T Martin; Paul T Martin
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

10.  Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer.

Authors:  Alison K Esser; Michael R Miller; Qin Huang; Melissa M Meier; Daniel Beltran-Valero de Bernabé; Christopher S Stipp; Kevin P Campbell; Charles F Lynch; Brian J Smith; Michael B Cohen; Michael D Henry
Journal:  J Biol Chem       Date:  2012-12-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.